ORIGINAL RESEARCH article
Front. Oncol.
Sec. Thoracic Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1563073
This article is part of the Research TopicInnovations in Biomarker-Based Lung Cancer ScreeningView all 10 articles
A Multimodal Nomogram for Benign-Malignant Discrimination of Lung-RADS ≥4A Nodules: Integration of Oxygen Enhanced Zero Echo Time MRI, CT Radiomics, and Clinical Factors
Provisionally accepted- Department of Radiology, The Fourth Hospital of Harbin Medical University, Harbin, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background and Objective: Lung-RADS ≥4A nodules require urgent intervention. Low-dose CT (LDCT), the primary screening tool, involves cumulative radiation exposure-critical for patients with serial scans.Oxygen-enhanced zero-echo time MRI (OE-ZTE-MRI) shows potential for lung nodule evaluation. However, its additive value when combined with CT radiomics and clinical factors for Lung-RADS ≥4A nodules remains unproven. This study aimed to develop a preoperative prediction model integrating OE-ZTE-MRI/CT radiomics and clinical factors for benign-malignant discrimination of Lung-RADS ≥4A nodules and compare its performance against single-modality models.Methods: 99 nodules from 84 prospectively enrolled patients undergoing both LDCT and OE-ZTE-MRI were included. Nodule boundaries were manually contoured as regions of interest (ROIs) on both modalities. Six machine learning classifiers were applied to radiomic features (extracted from LDCT and OE-ZTE-MRI) and clinical parameters (age, smoking history, nodule diameter, calcification, etc.). Model performance was evaluated using receiver operating characteristic (ROC) curves with area under the curve (AUC), complemented by decision curve analysis (DCA). Univariate and multivariate logistic regression identified independent predictors, which were incorporated into a final nomogram to visualize clinical-radiomic prediction. Results: MRI model had a similar diagnostic performance to CT model (MRI vs. CT: training cohort AUC: 0.854 vs 0.907; testing cohort AUC: 0.769 vs 0.798). Multi-radiomicsmodel achieved the highest diagnostic efficiency (train cohort AUC:0.923; testing cohort AUC: 0.813). Multivariate Logistic regression showed that nodule diameter (p=0.005) and calcification (p=0.029) were important factors affecting the benign and malignant nodules. The nomogram constructed by 3 models(CT/OE-ZTE-MRI/Clinical factors) achieved the best preoperative prediction performance for benign and malignant nodules (training cohort: AUC 0.941; testing cohort AUC:0.838). Conclusion: The nomogram combining OE-ZTE-MRI/CT radiomics and clinical factors (nodule diameter, calcification) improves preoperative discrimination of Lung-RADS ≥4A nodules (AUC=0.838), outperforming single-modality models. This tool enables evidence-based triage, potentially reducing unnecessary invasive procedures.
Keywords: Oxygen enhanced, CT, MRI, Radiomics, Multimodel analysis
Received: 19 Jan 2025; Accepted: 09 Jun 2025.
Copyright: © 2025 Yan and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Tong Zhang, Department of Radiology, The Fourth Hospital of Harbin Medical University, Harbin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.